finance.yahoo.com (nprofile…pkyy)
https://s.yimg.com/ny/api/res/1.2/W2IgyITSOXNnFeA265JwxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0a886363d77cee337ab330e5d82d25cb
https://finance.yahoo.com/news/why-iovance-biotherapeutics-tumbled-nearly-223909778.html
finance.yahoo.com / Yahoo! Finance
npub1va…rwc3n
2025-05-18 05:55:32
Author Public Key
npub1vap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aessgrwc3nPublished at
2025-05-18 05:55:32Event JSON
{
"id": "694c94759235bb29b509866709f5ac63a4c7d563971c4977ec78a18d486cf6a7",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1747547732,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/why-iovance-biotherapeutics-tumbled-nearly-223909778.html"
],
[
"subject",
"Why Iovance Biotherapeutics Tumbled by Nearly 6% Today"
],
[
"published_at",
"1747435149"
],
[
"image",
"https://s.yimg.com/ny/api/res/1.2/W2IgyITSOXNnFeA265JwxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0a886363d77cee337ab330e5d82d25cb"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://relay-testnet.k8s.layer3.news"
],
[
"imeta",
"url https://s.yimg.com/ny/api/res/1.2/W2IgyITSOXNnFeA265JwxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0a886363d77cee337ab330e5d82d25cb"
],
[
"t",
"finance:perspective"
],
[
"summary",
"The analyst, David Dai from UBS, cited concerns over the company's sales of its advanced melanoma drug Amtagvi, which were below expectations, and higher drop-out rates for the drug. He also expressed concern about the slow ramp-up of the company's commercialization and revenue guidance cut. The company's shares were negatively impacted by this downgrade, despite a positive day for the overall market."
]
],
"content": "nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy\nhttps://s.yimg.com/ny/api/res/1.2/W2IgyITSOXNnFeA265JwxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0a886363d77cee337ab330e5d82d25cb\n\nhttps://finance.yahoo.com/news/why-iovance-biotherapeutics-tumbled-nearly-223909778.html",
"sig": "69cd6c1c3f0338f6f878d95b3c5a2b504f25d0333396eb7744b83a46c353fe783db021a916b92de4380f30a3d92f5fd114556d454a7f5ffb60f76733f490c01b"
}